Adaptive extensions of a two-stage group sequential procedure for testing primary and secondary endpoints (I): unknown correlation between the endpoints

被引:20
作者
Tamhane, Ajit C. [1 ]
Wu, Yi [2 ]
Mehta, Cyrus R. [3 ,4 ]
机构
[1] Northwestern Univ, Dept IEMS, Evanston, IL 60208 USA
[2] Northwestern Univ, Dept Stat, Evanston, IL 60208 USA
[3] Cytel Corp, Cambridge, MA 02139 USA
[4] Harvard Univ, Sch Publ Hlth, Cambridge, MA 02139 USA
关键词
adaptive designs; familywise error rate; gatekeeping procedures; multiple comparisons; O'Brien-Fleming boundary; Pocock boundary; CLINICAL-TRIALS; DESIGN;
D O I
10.1002/sim.5372
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
In a previous paper we studied a two-stage group sequential procedure (GSP) for testing primary and secondary endpoints where the primary endpoint serves as a gatekeeper for the secondary endpoint. We assumed a simple setup of a bivariate normal distribution for the two endpoints with the correlation coefficient ? between them being either an unknown nuisance parameter or a known constant. Under the former assumption, we used the least favorable value of ??=?1 to compute the critical boundaries of a conservative GSP. Under the latter assumption, we computed the critical boundaries of an exact GSP. However, neither assumption is very practical. The ??=?1 assumption is too conservative resulting in loss of power, whereas the known ? assumption is never true in practice. In this part I of a two-part paper on adaptive extensions of this two-stage procedure (part II deals with sample size re-estimation), we propose an intermediate approach that uses the sample correlation coefficient r from the first-stage data to adaptively adjust the secondary boundary after accounting for the sampling error in r via an upper confidence limit on ? by using a method due to Berger and Boos. We show via simulation that this approach achieves 511% absolute secondary power gain for ? =0.5. The preferred boundary combination in terms of high primary as well as secondary power is that of O'Brien and Fleming for the primary and of Pocock for the secondary. The proposed approach using this boundary combination achieves 72-84% relative secondary power gain (with respect to the exact GSP that assumes known ?). We give a clinical trial example to illustrate the proposed procedure. Copyright (C) 2012 John Wiley & Sons, Ltd.
引用
收藏
页码:2027 / 2040
页数:14
相关论文
共 11 条
[1]   REPEATED SIGNIFICANCE TESTS ON ACCUMULATING DATA [J].
ARMITAGE, P ;
MCPHERSO.CK ;
ROWE, BC .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-GENERAL, 1969, 132 :235-&
[2]  
Armitage P., 1975, SEQUENTIAL MED TRIAL, V2nd
[3]   P-VALUES MAXIMIZED OVER A CONFIDENCE SET FOR THE NUISANCE PARAMETER [J].
BERGER, RL ;
BOOS, DD .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1994, 89 (427) :1012-1016
[4]   Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial [J].
Burge, PS ;
Calverley, PMA ;
Jones, PW ;
Spencer, S ;
Anderson, JA ;
Maslen, TK .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7245) :1297-1303
[5]   Hierarchical testing of multiple endpoints in group-sequential trials [J].
Glimm, Ekkehard ;
Maurer, Willi ;
Bretz, Frank .
STATISTICS IN MEDICINE, 2010, 29 (02) :219-228
[6]   Statistical considerations for testing multiple endpoints in group sequential or adaptive clinical trials [J].
Hung, H. M. James ;
Wang, Sue-Jane ;
O'Neill, Robert .
JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2007, 17 (06) :1201-1210
[7]  
Jennison C., 1999, GROUP SEQUENTIAL MET
[8]   DISCRETE SEQUENTIAL BOUNDARIES FOR CLINICAL-TRIALS [J].
LAN, KKG ;
DEMETS, DL .
BIOMETRIKA, 1983, 70 (03) :659-663
[9]   MULTIPLE TESTING PROCEDURE FOR CLINICAL-TRIALS [J].
OBRIEN, PC ;
FLEMING, TR .
BIOMETRICS, 1979, 35 (03) :549-556
[10]   GROUP SEQUENTIAL METHODS IN DESIGN AND ANALYSIS OF CLINICAL-TRIALS [J].
POCOCK, SJ .
BIOMETRIKA, 1977, 64 (02) :191-200